Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Optil 60mg modified-release tablets
0206020C0BQAAAA
|
Optil | Diltiazem hydrochloride | Cardiovascular System | No data available |
|
Optivate 1,000unit inf vials
0211000I0BLABAX
|
Optivate | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Optivate 250unit inf vials
0211000I0BLACBC
|
Optivate | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Optivate 500unit inf vials
0211000I0BLAAAW
|
Optivate | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Orgaran 750units/0.6ml solution for injection ampoules
0208010C0BBAAAA
|
Orgaran | Danaparoid sodium | Cardiovascular System | No data available |
|
Oxandosin XL 4mg tablets
0205040D0BHAAAQ
|
Oxandosin | Doxazosin mesilate | Cardiovascular System | No data available |
|
Oxprenolol 160mg modified-release tablets
0204000N0AAAFAF
|
Oxprenolol hydrochloride | Oxprenolol hydrochloride | Cardiovascular System | No data available |
|
Oxprenolol 20mg tablets
0204000N0AAABAB
|
Oxprenolol hydrochloride | Oxprenolol hydrochloride | Cardiovascular System | No data available |
|
Oxprenolol 40mg tablets
0204000N0AAACAC
|
Oxprenolol hydrochloride | Oxprenolol hydrochloride | Cardiovascular System | No data available |
|
Oxprenolol 80mg tablets
0204000N0AAADAD
|
Oxprenolol hydrochloride | Oxprenolol hydrochloride | Cardiovascular System | No data available |
|
Oxprenolol 80mg/5ml oral solution
0204000N0AAALAL
|
Oxprenolol hydrochloride | Oxprenolol hydrochloride | Cardiovascular System | No data available |
|
Parmid XL 10mg tablets
0206020F0BJABAC
|
Parmid (Felodipine) | Felodipine | Cardiovascular System | No data available |
|
Parmid XL 5mg tablets
0206020F0BJAAAB
|
Parmid (Felodipine) | Felodipine | Cardiovascular System | No data available |
|
Pentofin 400mg modified-release tablets
0206040AGBDAAAC
|
Pentofin | Pentoxifylline | Cardiovascular System | No data available |
|
Pentosan polysulfate sodium 50mg capsules
0208020I0AAABAB
|
Pentosan polysulfate sodium (Oral) | Pentosan polysulfate sodium | Cardiovascular System | No data available |
|
Pentoxifylline 100mg/5ml oral solution
0206040AGAAAFAF
|
Pentoxifylline | Pentoxifylline | Cardiovascular System | No data available |
|
Pentoxifylline 100mg/5ml oral suspension
0206040AGAAAGAG
|
Pentoxifylline | Pentoxifylline | Cardiovascular System | No data available |
|
Pentoxifylline 200mg/5ml oral solution
0206040AGAAAEAE
|
Pentoxifylline | Pentoxifylline | Cardiovascular System | No data available |
|
Percutol 2% ointment
0206010F0BHAAAF
|
Percutol | Glyceryl trinitrate | Cardiovascular System | No data available |
|
Perdix 15mg tablets
0205051C0BBABAB
|
Perdix | Moexipril hydrochloride | Cardiovascular System | No data available |
|
Perdix 7.5mg tablets
0205051C0BBAAAA
|
Perdix | Moexipril hydrochloride | Cardiovascular System | No data available |
|
Perfan 100mg/20ml solution for injection ampoules
0201020G0BBAAAA
|
Perfan | Enoximone | Cardiovascular System | No data available |
|
Perindopril erbumine 1mg/5ml oral liquid
0205051M0AAACAC
|
Perindopril erbumine | Perindopril erbumine | Cardiovascular System | No data available |
|
Perindopril erbumine 2mg oral powder sachets
0205051M0AAAJAJ
|
Perindopril erbumine | Perindopril erbumine | Cardiovascular System | No data available |
|
Perindopril erbumine 2mg/5ml oral suspension
0205051M0AAADAD
|
Perindopril erbumine | Perindopril erbumine | Cardiovascular System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.